floatz AI
verifiedAI for drug discovery surfacing high-potential targets; coherent though thin metadata.
What it does
floatz AI for Drug Discovery helps surface high-potential drug targets grounded in human genetics, expression patterns, and biological pathways, built for translational success. It integrates human genetics, tissue expression, and pathway analysis to map billions of concepts and identify targets with real translational potential, delivering 3 clinically-relevant targets in 14 days.
Core features
- ✦AI-driven drug target identification
- ✦Integration of human genetics, tissue expression, and pathway analysis
- ✦Delivery of 3 clinically-relevant targets in 14 days
- ✦Multi-layered analysis (literature, omics, disease biology, competitive intelligence)
- ✦Expert-reviewed target selection
Use cases
- →Identifying novel drug targets for specific disease areas
- →Expanding existing drug programs or exploring new therapeutic spaces
- →Informing strategic decision-making or licensing evaluation for drug development